The development of lymphomas in the Cdh5-CreERT2, Trp53R172H/R172H mice supports a strong selection for angiosarcoma formation following loss of p53 in contrast to expression of the gain-of-function mutant p53. The gene discussed is TP53; the disease is angiosarcoma.